Individuals Coming Off Weight-Loss Medications Put On Weight at a Quadrupled Rate Than Those on Conventional Diets

Fresh analysis indicates that people who discontinue popular weight-loss injections like semaglutide or tirzepatide tend to recover lost weight far faster than those who end traditional lifestyle plans.

Findings released in a leading health publication shows that while overweight people frequently drop about a fifth of their total mass while on the medication, the weight is regained at an estimated rate of 0.8 kg per month after stopping.

"Users buying these drugs should be aware of the potential of fast weight regain when the treatment ends," cautioned researcher Dr. Susan Jebb.

That rate of recovery implies a reversion to original weight in about one and a half years.

Analyzing Treatments

The analysis, which looked at dozens of trials involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with older methods.

Researchers note that individuals who shed pounds through diet and exercise generally experience a slower weight regain—around 0.1 kg a month—after stopping.

Explaining the Quick Regain

Doctors suggest the mode of action of the injections accounts for the amplified rebound.

GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Sustained high doses of GLP-1 concentrations several times higher than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a dietetics expert.

"Stopping of this medication means appetite is uncontrolled, making excessive eating a significant risk."

A Lifelong Issue?

Health authorities recommend the jabs for people with obesity-related health risks, alongside prescribed diet and exercise modifications.

Many experts say that, considering the significant potential of relapse, the treatment is often long-term.

This view is supported by drug manufacturers, who note that the results "underscore the chronic nature of excess weight," similar to managing diseases like high blood pressure.

User Accounts

People who have discontinued the jabs explain a intense resurgence of hunger.

"It was like a trigger that goes on and you become ravenous," recalled a patient.

This difficulty is exacerbated if individuals have not developed permanent dietary or behavioural modifications during treatment.

Growing Use

Survey data suggest that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.

• Adoption is greater among women than men.
• The 40s and 50s age group shows the greatest usage rates.
• A large proportion access the medications through private prescriptions rather than the NHS.

Ultimately, researchers stress that while these medications are effective tools for shedding pounds, they are not a standalone cure and long-term success likely depends on integrated behavioural support.